This is an exclusive BHB+ story.
The year kicked off with five major digital behavioral health acquisitions, signaling that the COVID-era boom of these digital products has reached a state of normalization. The market area is at least on the cusp of a true consolidation cycle, if not fully in it yet, industry insiders told Behavioral Health Business.
The acquisitions largely reflect a push from larger players to control more of the care continuum and add on service specializations.
Much of the activity kicked off in late January with virtual OCD provider NOCD’s acquisition of trauma care provider Rebound Health. The two rebranded under the name Noto and now operate as a specialty behavioral health company.
Shortly after that, global mental health benefits platform Spring Health announced its acquisition of Alma, a digital platform that supports clinicians with payer contracting and streamlines workflows.
Then, in February, virtual mental health platform Grow Therapy acquired Tenor Therapy, a HIPAA-compliant, AI-powered clinical support tool that generates therapy notes and assists with documentation. Not long after, Grow Therapy raised a $150 million Series D round, indicating investor support for its strategic direction, and its valuation shot up to $3 billion.
March, which still has one week left in it, has seen two more major acquisitions in the digital mental health space. On March 9, Universal Health Services (NYSE: UHS) announced its $835 million acquisition of Talkspace (Nasdaq: TALK). The deal will officially close during the third quarter of 2026.
Just two weeks after that major deal, digital behavioral health unicorn Cerebral acquired ADHD management app Inflow in a move that Cerebral’s CEO Brian Reinken told BHB aims to strengthen patient engagement.
All of these deals involve tech-enabled behavioral health companies eyeing specific areas like OCD, trauma, ADHD, etc., to expand capabilities through infrastructure-focused acquisitions.
Anna Wang, vice president of GreyMatter Capital, an early-stage venture capital firm focused on mental health and behavioral health innovations, said the market activity is akin to a genuine “renaissance” in digital mental health.
“All of these continued raises are now happening six-plus years after COVID and after the peak valuations that we saw within venture and public markets,” Wang told BHB. “With that backdrop, consolidation really is a clear signal that the market is reaching this level of maturity in mental health. These acquirers are putting real money into these deals, and it validates a category that is a great one for the next generation of founders and builders who are looking for that exit validation and exit roadmap.”
She attributes the activity to high-quality platforms and the rising importance of clinical models and specialization areas. The two main drivers of consolidation in the digital behavioral health space right now are a combination of a strong supply of attractive acquisition targets and the availability of capital from their prospective buyers, Wang said.
“I suspect that we probably will see more consolidations in the market,” Wang said. “Each of these deals probably had slightly different end goals and intent on that, but there are just so many great assets in the market right now, and still many companies out there with a lot of cash on their balance sheet. The combination of those two factors leads me to believe that we will see more consolidation.”
Multiple insiders from various sectors of the industry, from M&A advisory firms to investment banking, agreed with Wang’s projection. That trend, especially due to the sheer volume of digital behavioral health-focused solutions on the market, is likely to continue.
Rather than traditional brick-and-mortar expansion via consolidation activity, active buyers in the market right now are eyeing acquisitions that build on their assets and future-proof their strategies.
“It takes time to build the platform or the software or the technology itself… sometimes, if you have the infrastructure, the way to leverage that [is] just through an acquisition…” Connor Cruse, managing director at Vertess, a health care-focused M&A advisory firm, told BHB. “I think we’ll see it continue… these are all very strategic acquisitions that are taking place.”
The real strategy at play here is larger buyers’ aim to “continue to own the continuum and then also wanting to do more with it,” he explained.
John Smith, CEO of Impact Investment Groups, a behavioral health-focused impact investment and operating platform that invests in and helps scale healthcare services businesses, particularly for underserved populations, echoed this.
“From the impact investment perspective… the opportunity [is] thoughtful consolidation of fragmented behavioral health providers and technology, so that we can now put that into a scalable platform that can improve care delivery and then generate a very strong financial and social return,” Smith told BHB.
From his vantage point, Smith will be keeping tabs on the pace and shape of how strategic platform roll-ups continue to play out, the growth of new digital tools and AI-powered platforms, and how payer relationships and regulatory uncertainties affect the market.
“There’s going to be a lot of activity… based on what is happening now, even with current regulation, the government, and Medicaid, they know that behavioral health is not going anywhere,” Smith said. “This population is not going anywhere. Medicaid is not going anywhere. They can cut costs, but it’s not going anywhere. So it’s more recession-proof, so to speak… so you will see an increase in the number of activities in that space that allows investors to invest in an operator who knows how to run and operate behavioral health companies very well.”
Jonathan Bluth, managing director at Brown Gibbons Lang & Company, a middle-market investment bank and financial advisory firm that specializes in health care, said from his perspective the market is “right on the verge” of what will likely become a “true consolidation cycle.”
What could be on the horizon from his perspective is more consolidation across tools like revenue cycle management (RCM) and related platforms, specifically tailored to the behavioral health field.
“There are several really interesting companies that have grown rapidly with a dedicated niche where they are the specialist,” Bluth told BHB. “That’s great, but that demand is now massive from providers who desperately need the help with fairly traditional revenue cycle solutions. So, I expect that what we will see are large, multi-specialty, comprehensive RCM companies consolidating into specialty RCM businesses.”
Ease Health — a company that recently launched from stealth with $41 million — as an all-in-one RCM, electronic health record (EHR) and customer relationship management (CRM) platform for behavioral health providers, could be a prime target for the type of market consolidation Bluth expects to see in the future.
For now, what’s most likely in the space, Bluth said, is to see digital solutions refine as technology continues to mature, infuse new capabilities like AI, and improve to the point they become attractive for large buyers to jump at.
“I don’t think that the digitization of behavioral health is being driven by AI,” Bluth said. “I do think that everything that we do everywhere in health care is being impacted. I think that everyone is looking at new use cases and experimenting with AI. Every single provider group is trying to figure out what they can do, testing new systems, but I don’t think that’s the reason why there’s greater adoption of tele-behavioral systems… I think that the solutions themselves are just better. I think it’s a natural evolution of capabilities.”